FIELD OF THE INVENTION
This invention is directed to tetrahydro-1H-1,2,6-triaza-azulene cannabinoid (CB) modulator compounds and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
BACKGROUND OF THE INVENTION
Before the discovery of